Improving Perioperative Cardiac Risk Stratification in Liver Transplant: A New Role for Coronary Computed Tomography Angiography?
Arun B. Jesudian – 11 September 2020
Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis
Kim H. H. Liss, Shelby E. Ek, Andrew J. Lutkewitte, Terri A. Pietka, Mai He, Priya Skaria, Eric Tycksen, Daniel Ferguson, Valerie Blanc, Mark J. Graham, Angela M. Hall, Mitchell R. McGill, Kyle S. McCommis, Brian N. Finck – 11 September 2020 – Nonalcoholic fatty liver disease (NAFLD) is becoming the most common indication for liver transplantation.
Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis
Mary J. Thomson, Anna S. F. Lok, Elliot B. Tapper – 10 September 2020
Environmental Pollution and the Developmental Origins of Childhood Liver Disease
Matthew C. Cave – 10 September 2020
Obesity and Liver Decompensation
Joseph C. Ahn, Vinay Sundaram – 9 September 2020
Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives
Claudia Pinto Marques Souza de Oliveira, Helma Pinchemel Cotrim, Marco Arrese – 9 September 2020
Patient With Nonalcoholic Steatohepatitis Posttransplant Develops Acute Hepatitis B Virus Causing Graft Failure
Amanda Chaney – 9 September 2020
Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin Medications
Christopher Kasia, Steven J. Scaglione – 9 September 2020
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Ezequiel Ridruejo, Alejandro Soza – 9 September 2020
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Daniel Berger, Vishal Desai, Sujit Janardhan – 9 September 2020